<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02042638</url>
  </required_header>
  <id_info>
    <org_study_id>27122013</org_study_id>
    <nct_id>NCT02042638</nct_id>
  </id_info>
  <brief_title>The Effects of Gonadotropin Replacement Therapy in Patients With Hypogonadism</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gulhane School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gulhane School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Effects of hCG replacement therapy on metabolic syndrome parameters in hypogonadotrophic
      hypogonadism.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>HDL after hCG treatment</measure>
    <time_frame>2011-2013</time_frame>
    <description>2011-2013</description>
  </primary_outcome>
  <primary_outcome>
    <measure>LDL levels after hCG treatment</measure>
    <time_frame>2011-2013</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>total cholesterole levels after hCG treatment</measure>
    <time_frame>2011-2013</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body fat ratio after hCG treatment</measure>
    <time_frame>2011-2013</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hsCRP levels after hCG treatment</measure>
    <time_frame>2011-2013</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">16</enrollment>
  <condition>Idiopathic Hypogonadotropic Hypogonadism</condition>
  <arm_group>
    <arm_group_label>16 treatment naive Hypogonadotropic hypogonadism patients</arm_group_label>
    <description>Treatment naive 16 patients with idiopathic hypogonadotrophic hypogonadism</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>hCG 1500 IU three times a week</intervention_name>
    <arm_group_label>16 treatment naive Hypogonadotropic hypogonadism patients</arm_group_label>
    <other_name>Pregnyl (Organon) ampule 1500 IU</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregnyl (hCG) ampule 1500 IU/three times a week</intervention_name>
    <arm_group_label>16 treatment naive Hypogonadotropic hypogonadism patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Idiopathic Hypogonadotropic Hypogonadism
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: Serum testosterone concentration &lt; 300ng/dL Absence of a pituitary or
        hypothalamic mass lesions, Presence of gonadotropin response to GnRH, -

        Exclusion Criteria: Previous androgen treatment, diabetes mellitus, arterial hypertension
        other hormone deficiencies
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fahri Bayram, Proffesor</last_name>
    <role>Study Director</role>
    <affiliation>Erciyes University School of Medicine Depatment of Endocrinology and Metabolism Kayseri TURKEY</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gulhane School of Medicine Dep. of Endocrinology and Metabolism</name>
      <address>
        <city>Ankara</city>
        <zip>06018</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 28, 2013</study_first_submitted>
  <study_first_submitted_qc>January 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2014</study_first_posted>
  <last_update_submitted>January 22, 2014</last_update_submitted>
  <last_update_submitted_qc>January 22, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gulhane School of Medicine</investigator_affiliation>
    <investigator_full_name>Aydogan Aydogdu</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypogonadism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chorionic Gonadotropin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

